• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地拉罗司诱发的高氨血症和范科尼综合征:一例报告

Deferasirox-induced hyperammonemia and Fanconi syndrome: a case report.

作者信息

Zhou Houfu, Xiong Daoxue, Feng Yan, Jiang Jianyu

机构信息

Intensive Care Unit, Chongqing University Three Gorges Hospital, Chongqing, Wanzhou, China.

出版信息

Front Pediatr. 2024 Oct 10;12:1461867. doi: 10.3389/fped.2024.1461867. eCollection 2024.

DOI:10.3389/fped.2024.1461867
PMID:39449753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11499891/
Abstract

BACKGROUND

The exact mechanism of hyperammonemia is thought to be multifactorial, but is not yet fully understood. No studies have yet reported hyperammonemia combined with Fanconi syndrome caused by deferasirox.

CASE PRESENTATION

A 10-year-old girl was admitted for vomiting and altered consciousness. Blood testing revealed hyperammonemia and normal liver and coagulation functions. During hospitalization, the patient also exhibited hyperchloremic metabolic acidosis, hypokalemia, hyponatremia, and hypophosphatemia. Additionally, urinalysis revealed glucose and protein levels clinically consistent with Fanconi syndrome. The patient had a history of severe beta-thalassemia and had received intermittent blood transfusions for approximately ten years. The patient had been administered oral deferasirox at a 400 mg/day dose at the age of four, which had been gradually increased to the current 750 mg/day dosage. Upon admission, deferasirox was discontinued and treatment including mechanical ventilation, continuous blood purification therapy for ammonia reduction and acidosis, and electrolyte imbalance corrections was administered. Subsequently, serological markers returned to normal, urine test findings improved. To the best of our knowledge, this is the first report of a case of hyperammonemia with Fanconi syndrome owing to deferasirox.

CONCLUSIONS

For effective management and long-term follow-up of chronic diseases in children, pediatricians must master standardized treatments and the adverse reactions of various drugs. When symptoms are difficult to explain clinically, we must trace the source and adjust the treatment plan to maximize improving the patient's prognosis.

摘要

背景

高氨血症的确切机制被认为是多因素的,但尚未完全明确。尚无研究报道去铁胺引起的高氨血症合并范科尼综合征。

病例报告

一名10岁女孩因呕吐和意识改变入院。血液检查显示高氨血症,肝功能和凝血功能正常。住院期间,患者还出现高氯性代谢性酸中毒、低钾血症、低钠血症和低磷血症。此外,尿液分析显示葡萄糖和蛋白质水平与范科尼综合征临床相符。该患者有严重β地中海贫血病史,已接受间歇性输血约十年。患者四岁时开始口服去铁胺,剂量为400毫克/天,逐渐增加至目前的750毫克/天。入院后,停用去铁胺,并给予包括机械通气、持续血液净化治疗以降低氨水平和纠正酸中毒及电解质失衡在内的治疗。随后,血清学指标恢复正常,尿液检查结果改善。据我们所知,这是首例因去铁胺导致高氨血症合并范科尼综合征的病例报告。

结论

对于儿童慢性疾病的有效管理和长期随访,儿科医生必须掌握标准化治疗方法及各种药物的不良反应。当临床症状难以解释时,必须追查病因并调整治疗方案,以最大程度改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ff/11499891/5098006985ad/fped-12-1461867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ff/11499891/5098006985ad/fped-12-1461867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ff/11499891/5098006985ad/fped-12-1461867-g001.jpg

相似文献

1
Deferasirox-induced hyperammonemia and Fanconi syndrome: a case report.地拉罗司诱发的高氨血症和范科尼综合征:一例报告
Front Pediatr. 2024 Oct 10;12:1461867. doi: 10.3389/fped.2024.1461867. eCollection 2024.
2
Hyperchloremic metabolic acidosis due to deferasirox in a patient with beta thalassemia major.继发于地拉罗司治疗的β-地中海贫血患者的高氯性代谢性酸中毒。
Ann Pharmacother. 2010 Jan;44(1):219-21. doi: 10.1345/aph.1M440. Epub 2009 Nov 24.
3
Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male.地拉罗司致肝损伤及范可尼综合征 1 例:β 地中海贫血男性患者
BMJ Case Rep. 2020 Jul 9;13(7):e234542. doi: 10.1136/bcr-2020-234542.
4
Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.因使用地拉罗司而患有肾性范科尼综合征的依赖输血的地中海贫血患者。
Nephrology (Carlton). 2015 Dec;20(12):931-5. doi: 10.1111/nep.12523.
5
Recurrent noncirrhotic hyperammonemia causing acute metabolic encephalopathy in a patient with a continent ileocecal pouch: a case report.患者具有回肠贮袋-可控性乙状结肠肛门吻合术,反复非肝硬化性高氨血症引起急性代谢性脑病:病例报告。
J Med Case Rep. 2021 May 22;15(1):294. doi: 10.1186/s13256-021-02842-1.
6
Deferasirox-associated Fanconi syndrome in adult patients with transfusional iron overload.去铁酮相关性范可尼综合征在输血致铁过载成年患者中的表现。
Vox Sang. 2021 Aug;116(7):793-797. doi: 10.1111/vox.13064. Epub 2021 Feb 2.
7
A case of entecavir-induced Fanconi syndrome.1例恩替卡韦诱发的范科尼综合征。
CEN Case Rep. 2019 Nov;8(4):256-260. doi: 10.1007/s13730-019-00404-5. Epub 2019 Jun 1.
8
Proximal Renal Tubular Acidosis (Fanconi Syndrome) Induced by Apremilast: A Case Report.阿普米司特致近端肾小管酸中毒(范可尼综合征):病例报告。
Am J Kidney Dis. 2017 Nov;70(5):729-731. doi: 10.1053/j.ajkd.2017.06.021. Epub 2017 Aug 18.
9
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.甲磺酸去铁胺用于治疗依赖输血的地中海贫血患者的输血性铁过载。
Cochrane Database Syst Rev. 2013 Aug 21;2013(8):CD004450. doi: 10.1002/14651858.CD004450.pub3.
10
A case report of deferasirox-induced kidney injury and Fanconi syndrome.地拉罗司致肾损伤及范科尼综合征一例报告
WMJ. 2013 Aug;112(4):177-80.

本文引用的文献

1
Drug-induced hyperammonaemia.药物引起的血氨过高。
J Clin Pathol. 2023 Aug;76(8):501-509. doi: 10.1136/jcp-2022-208644. Epub 2023 May 10.
2
Hyperammonemia Due to Empyema.脓胸导致的血氨过高。
Intern Med. 2023 Sep 1;62(17):2527-2529. doi: 10.2169/internalmedicine.0922-22. Epub 2023 Feb 1.
3
Deferasirox-associated Fanconi syndrome in adult patients with transfusional iron overload.去铁酮相关性范可尼综合征在输血致铁过载成年患者中的表现。
Vox Sang. 2021 Aug;116(7):793-797. doi: 10.1111/vox.13064. Epub 2021 Feb 2.
4
Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy.儿童连续性肾脏替代治疗患者高血氨管理的共识指南。
Nat Rev Nephrol. 2020 Aug;16(8):471-482. doi: 10.1038/s41581-020-0267-8. Epub 2020 Apr 8.
5
Effects of deferasirox dose and decreasing serum ferritin concentrations on kidney function in paediatric patients: an analysis of clinical laboratory data from pooled clinical studies.去铁酮剂量和降低血清铁蛋白浓度对儿科患者肾功能的影响:来自汇集临床研究的临床实验室数据分析。
Lancet Child Adolesc Health. 2019 Jan;3(1):15-22. doi: 10.1016/S2352-4642(18)30335-3. Epub 2018 Nov 17.
6
Acute hyperammonemia in children under deferasirox treatment: cutting the Gordian knot.接受地拉罗司治疗的儿童急性高氨血症:快刀斩乱麻。
Clin Toxicol (Phila). 2019 May;57(5):375-377. doi: 10.1080/15563650.2018.1523425. Epub 2018 Nov 16.
7
Hyperammonemia After Blood Transfusion.输血后高氨血症
Ann Intern Med. 2018 Feb 20;168(4):306. doi: 10.7326/L17-0641.
8
Deferasirox-induced serious adverse reaction in a pediatric patient: pharmacokinetic and pharmacogenetic analysis.地拉罗司在一名儿科患者中引起的严重不良反应:药代动力学和药物遗传学分析。
Eur J Clin Pharmacol. 2016 Feb;72(2):247-8. doi: 10.1007/s00228-015-1956-2. Epub 2015 Sep 24.
9
Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia.地拉罗司相关肾小管功能障碍在儿童和年轻成人β地中海贫血患者中的发生率。
Br J Haematol. 2014 Nov;167(3):434-6. doi: 10.1111/bjh.13002. Epub 2014 Jul 2.
10
Ammonia clearance with haemofiltration in adults with liver disease.血液滤过清除成人肝病患者的氨。
Liver Int. 2014 Jan;34(1):42-8. doi: 10.1111/liv.12221. Epub 2013 Jun 20.